首页> 外文期刊>International journal of hematology-oncology and stem cell research. >The comparison of plasma D-dimer levels in benign and malignant tumors of cervix, ovary and uterus
【24h】

The comparison of plasma D-dimer levels in benign and malignant tumors of cervix, ovary and uterus

机译:子宫颈,卵巢和子宫良性和恶性肿瘤血浆D-二聚体水平的比较

获取原文
           

摘要

Background: Thromboembolism is the most important complication of cancers.The aim of this study was to determine D-dimer levels in benign and malignant tumors of the uterus, ovary and cervix. Subjects and Methods: This was a cross sectional study and it was conducted on 90 female patients referred to Imam Khomeini and Arash Hospitals because of uterine, cervical and ovarian tumors in 2013-2014. After surgical resection or tissue biopsy, 2 cc of each patient’s blood was taken to be sent to laboratory of hospitals. “Nycocard” kit was chosen to measure D-dimer levels in Mg/Lit by neflumetry method. Data were analyzed in SPSS-16 by T-test and One-Way ANOVA test. Results: The highest mean of D-dimer was 3.9 (± 2.9SD) in malignant cervical tumors. The mean plasma levels of D-dimer in malignant uterine cancers (P = 0.008), ovarian cancers (P = 0.007) and cervical cancers (P = 0.006) was significantly higher than benign tumors. In all three types of uterine, ovarian and cervical cancers, D-dimer was significantly higher in advanced stages than lower stages. Conclusion: The plasma D-dimer levels in patients with malignant tumors of the uterus, cervix and ovary were higher than benign types. By increasing the stage of gynecologic malignant tumors, the levels of plasma D-dimer were increased.Key Words: D-dimer, Gynecologic Tumors, Tromboembolism, Coagulation
机译:背景:血栓栓塞症是最重要的癌症并发症。本研究的目的是确定子宫,卵巢和子宫颈良性和恶性肿瘤中的D-二聚体水平。受试者与方法:这是一项横断面研究,于2013-2014年对90名因子宫,宫颈和卵巢肿瘤而转诊至Imam Khomeini和Arash医院的女性患者进行了研究。进行手术切除或组织活检后,每位患者的血液中均抽取2 cc送往医院的实验室。选择了“ Nycocard”试剂盒,通过浊度法测量Mg / Lit中的D-二聚体水平。通过T检验和单向ANOVA检验在SPSS-16中分析数据。结果:恶性宫颈肿瘤中D-二聚体的最高平均值为3.9(±2.9SD)。恶性子宫癌(P = 0.008),卵巢癌(P = 0.007)和宫颈癌(P = 0.006)的平均血浆D-二聚体水平显着高于良性肿瘤。在所有三种类型的子宫癌,卵巢癌和宫颈癌中,晚期的D-二聚体明显高于晚期的D-二聚体。结论:子宫,子宫颈和卵巢恶性肿瘤患者血浆D-二聚体水平高于良性肿瘤。通过增加妇科恶性肿瘤的分期,血浆D-二聚体水平升高。关键词:D-二聚体,妇科肿瘤,血栓栓塞,凝血

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号